Articles, App Notes, Case Studies, & White Papers

  1. Development And Optimization Of LNP Formulations 12/6/2024

    The production of lipid nanoparticles (LNPs) is a process that demands robustness, scalability, and reproducibility. Examine the impact of key operational parameters on the efficacy of LNPs.

  2. Molecular Weight Confirmation For Length, Integrity And Impurity Analysis Of A 70-Mer Oligonucleotide 9/8/2023

    Explore a workflow used to determine the molecular weight and analyze the purity of a 70-mer DNA sequence with a 3’ dT overhang.

  3. Advanced Therapies Going Mainstream: Are We There Yet? 11/14/2025

    Advanced therapies are nearing mainstream adoption, with cell, mRNA, and oligonucleotide treatments expanding into broader indications. Learn what’s driving this shift and what manufacturers must do.

  4. Phase I Trials Global Clinical Trial Landscape – Focus On Asia Pacific 5/9/2023

    Unearth key trends in global Phase I trials, including highlights from the top therapeutic areas, indications, and biologic drug types in popular trial regions of Asia Pacific, the United States, and Europe.

  5. Nucleic Acid Therapeutics And Environmental Impact 4/11/2024

    Nucleic acid therapeutics offer exciting new avenues of treatment. Learn about the history of nucleic acid therapeutics and the environmental impact of manufacturing mRNA and oligonucleotides.

  6. An Exploration Of ICIs In Cancer Therapy 1/31/2024

    This collection of frequently asked questions highlights the remarkable efficacy of immune checkpoint inhibitors (ICIs) and the projected growth of the global ICI market.

  7. Chronic Lymphocytic Leukemia: Global Clinical Trial Landscape (2024) 8/19/2024

    CLL is slow-progressing leukemia primarily affecting older adults. Get the latest information on research, innovative therapies, and emerging clinical trials shaping CLL care by downloading this report.

  8. How LNP Technology Meets The Delivery Need Of saRNA Vaccines 6/22/2023

    Explore challenges to the successful development of RNA-based drugs and vaccines as well as the advantages of utilizing lipid nanoparticle technology as a delivery platform for saRNA.

  9. Benefits And Challenges Of Driving Modernization In Vaccine Development 6/11/2019

    Protein Sciences learned several valuable lessons during the development and final regulatory approval of its recombinant hemagglutinin (rHA) influenza vaccine, Flublok.

  10. Visualizing Airflow With Smoke Studies For Aseptic Manufacturing Excellence 7/7/2025

    JHS uses smoke studies to visualize airflow in cleanrooms, ensuring aseptic conditions and regulatory compliance for sterile pharmaceutical production, especially on new aseptic filling lines.